<?xml version="1.0" encoding="UTF-8"?>
<p>While BCG generally is regarded as safe, hematogenous dissemination of 1% following ID administration has reported, mainly in infants with HIV infection and other forms of immunosuppression 
 <sup>
  <xref rid="ref-32" ref-type="bibr">32</xref>
 </sup>. For this reason, BCG is contraindicated for use in immunosuppressed infants. The potential for developing serious complications, including death, following uncontrolled hematogenous dissemination when administered to immunosuppressed infants represents an important rationale driving the need for replacing BCG with a safer TB vaccine that can be administered to all infants, regardless of HIV infection status or immune competence.
</p>
